Target intelligence / Profile preview

Measles morbillivirus hemagglutinin and fusion glycoproteins (MeV H and F)

Target
MeV H and F
Molecular classification
Viral surface protein, Glycoprotein
01

Overview

The Measles morbillivirus envelope glycoproteins, Hemagglutinin (H) and Fusion (F), are the primary mediators of viral entry into host cells. The H protein is a type II transmembrane glycoprotein that functions as the attachment protein, recognizing and binding to specific host receptors such as signaling lymphocytic activation molecule (SLAM/CD150) on immune cells and Nectin-4 on epithelial cells (UniProt P08362). Upon receptor binding, the H protein undergoes a conformational change that is transmitted to the F protein, a type I transmembrane glycoprotein (UniProt P03372). This trigger causes the F protein to transition from a metastable pre-fusion state to a stable post-fusion state, inserting a fusion peptide into the host cell membrane and facilitating the merger of the viral and cellular membranes (Plemper et al., 2011). These glycoproteins are the principal targets of the host's neutralizing antibody response and are the key antigenic components of the live-attenuated measles vaccine. In addition to their role in primary infection, mutations in these proteins are associated with the development of subacute sclerosing panencephalitis (SSPE), a fatal neurodegenerative disease (Navaratnarajah et al., 2016). Therapeutic strategies targeting H and F include the use of neutralizing antibodies for post-exposure prophylaxis and the development of small-molecule fusion inhibitors like AS-48. Understanding the structural dynamics of the H-F complex is crucial for designing next-generation antivirals that can block viral entry and prevent the spread of measles.

Other names
Measles virus H and F proteinsMeV envelope glycoproteinsHemagglutinin (H) proteinFusion (F) proteinAttachment and fusion proteins
02

Mechanism of action

The H protein binds to host receptors (CD150/SLAM or Nectin-4), which triggers the F protein to undergo a conformational change, leading to the fusion of the viral envelope with the host cell membrane and subsequent viral entry (Navaratnarajah et al., 2016).

03

Biological functions

Viral attachmentMembrane fusionViral entrySyncytia formationImmune responseOther
04

Disease associations

InfectionNeurodegenerative disease
05

Safety considerations

Viral resistance through escape mutationsPotential for antibody-dependent enhancementHypersensitivity to vaccine components
06

Interacting drugs

Measles vaccine

4 more in the full profile.

07

Biomarkers

Anti-measles H antibody titerAnti-measles F antibody titerMeasles virus RNANeutralizing antibody levels

Beyond the preview

Go deeper on Measles morbillivirus hemagglutinin and fusion glycoproteins (MeV H and F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Measles morbillivirus hemagglutinin and fusion glycoproteins (MeV H and F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call